OsteoCentric Technologies appears in FDA premarket notification records as the applicant for cannulated fastener and nut systems classified under 21 CFR 888.3040, the regulation for smooth or threaded metallic bone fixation fasteners in Class II. The supplied collection contains one linked 510(k) record, K263116, decided Substantially Equivalent on October 2, 2026, and the sample decision count for that single record is also one. Earlier clearances in the numbered sources, K210754, K211290 and K242691, show the same device family and regulation across 2021 and 2024. Company-published pages describe the fastener systems and the Unifi MI technology in the company's own terms. [1][3][6][8]
The 2026 clearance and its scope
K263116 covers devices named OsteoCentric Technologies Cannulated and Soild Fasteners with Nuts, with product code HWC, advisory committee Orthopedic, and a decision of Substantially Equivalent dated October 2, 2026. The submission was received September 4, 2026, and the clearance type is listed as Special, with a summary statement and no third-party review. The FDA record lists the applicant at 75 W 300 N, Suite 150, Logan, UT 84321, which is a filing address rather than a verified headquarters. [1]
The device falls under regulation number 888.3040, described in the record as Screw, Fixation, Bone, device class 2, medical specialty Orthopedic. That classification places the clearance within the established bone fixation fastener category rather than a new device type. [1]
Earlier submissions in the same family
K210754, dated April 14, 2021, covers Cannulated Fasteners and Nuts under 21 CFR 888.3040, Class II, product codes HWC and HTN. The FDA letter states that the subject devices are similar to previously cleared Cannulated Screws (K170021) and that the indications for use match those of the previously cleared predicates. [6]
K211290, dated July 1, 2021, carries the same trade name, regulation and product codes. Its performance data section states that no performance testing was required because no physical changes were made to the devices, the size ranges are comparable to predicate devices with the same indications, and no additional testing was required for the proposed indication modifications. [8]
K242691, dated September 5, 2024, again names OsteoCentric Technologies Cannulated Fasteners and Nuts under 21 CFR 888.3040, Class II, product codes HWC and HTN. The FDA letter is addressed to the company's Vice President of Quality & Regulatory Affairs at the Logan, Utah address. [3]
Products and technology as published by the company
The company's current products page lists a 7.0mm and 8.0mm Cannulated Fastener Set with full thread, 24mm partially threaded, and variable thread options, plus a 7.0mm and 8.0mm Cannulated Nut System. The page attributes these products to Unifi MI Technology and states that the technology resists multi-planar and multi-directional loads through Mechanical Integration. [4]
A separate product page describes the OsteoCentric Trauma Cannulated Fasteners as cannulated fasteners in a variety of lengths and diameters, provided non-sterile and manufactured from Stainless Steel per ASTM F138. The same page states that the design is intended to engage twice as much bone when loaded in any direction as compared to standard screws, a company characterization rather than an independently verified finding. [5]
The company homepage describes Unifi MI Interface Technology as designed to preserve the native architecture of bone during implantation, with the stated intent of improving a patient's path to recovery. The page also notes OsteoCentric's acquisition of the Integrity SI-Fusion System, without further detail on terms or timing. [7]
Identity and what the record does not establish
Across the numbered FDA letters, OsteoCentric Technologies is the named applicant, and correspondence is routed through regulatory representatives at Empirical Testing Corp. in Colorado Springs in the 2021 letters. The company's own pages list a corporate office in Austin, Texas, and a design center at the Logan, Utah address that also appears in FDA filings. No parent company, brand ownership or customer relationships are verified in the public documents. [3][6][7][8]
The linked collection is a snapshot of supplied filings, not a measure of total portfolio, sales or safety performance. No recall records appear in the supplied sample, and the absence of recalls in that sample does not establish a safety record. Commercial availability, pricing and clinical outcomes are not documented in the numbered sources. [1]

